Helix BioPharma Corp. (TSE:HBP – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$2.27 and traded as low as C$2.03. Helix BioPharma shares last traded at C$2.06, with a volume of 313 shares traded.
Helix BioPharma Price Performance
The company has a 50 day simple moving average of C$2.27 and a 200-day simple moving average of C$1.66. The stock has a market capitalization of C$157.34 million, a P/E ratio of -29.43 and a beta of 0.37.
Helix BioPharma (TSE:HBP – Get Free Report) last posted its quarterly earnings results on Wednesday, October 29th. The biopharmaceutical company reported C($0.01) earnings per share for the quarter. The firm had revenue of C$0.31 million during the quarter. As a group, equities analysts forecast that Helix BioPharma Corp. will post -0.11 earnings per share for the current fiscal year.
About Helix BioPharma
Helix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today’s hardest-to-treat cancers. The Company’s pipeline is led by Tumor Defense Breaker¿ L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today’s front-running anti-cancer treatments.
Featured Articles
- Five stocks we like better than Helix BioPharma
- The Significance of Brokerage Rankings in Stock Selection
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Business Services Stocks Investing
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- Earnings Per Share Calculator: How to Calculate EPS
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Helix BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
